<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">zsXLqYCZrWWn6N8SftRBxyp</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2012001500006</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(12)09900600006</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2012005000106</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigo Original</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Fibrila&#231;&#227;o atrial e dem&#234;ncia: resultados do S&#227;o Paulo ageing &amp; health study</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Kawabata-Yoshihara</surname>
            <given-names>Liz Andrea</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Scazufca</surname>
            <given-names>M&#225;rcia</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Santos</surname>
            <given-names>Itamar de Souza</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Whitaker</surname>
            <given-names>Aristarcho</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kawabata</surname>
            <given-names>Vitor S&#233;rgio</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bense&#241;or</surname>
            <given-names>Isabela Martins</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Menezes</surname>
            <given-names>Paulo Rossi</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lotufo</surname>
            <given-names>Paulo Andrade</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">SP</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade de S&#227;o Paulo</institution>
        <institution content-type="orgdiv1">Hospital Universit&#225;rio </institution>
        <country country="BR">Brasil</country>
      </aff>
      <aff id="aff03">
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">SP</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade de S&#227;o Paulo</institution>
        <institution content-type="orgdiv1">Faculdade de Medicina </institution>
        <institution content-type="orgdiv2">Hospital das Cl&#237;nicas</institution>
        <country country="BR">Brasil</country>
      </aff>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">SP</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade de S&#227;o Paulo</institution>
        <institution content-type="orgdiv1">Faculdade de Medicina </institution>
        <country country="BR">Brasil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>12</month>
        <year>2012</year>
      </pub-date>
      <volume>99</volume>
      <issue>6</issue>
      <fpage>1108</fpage>
      <lpage>1114</lpage>
      <history>
        <date date-type="received">
          <day>10</day>
          <month>04</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>01</day>
          <month>08</month>
          <year>2012</year>
        </date>
        <date date-type="rev-recd">
          <day>12</day>
          <month>04</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: A fibrila&#231;&#227;o atrial &#233; um fator de risco controverso para dem&#234;ncia. OBJETIVO: O objetivo deste estudo &#233; avaliar a associa&#231;&#227;o entre fibrila&#231;&#227;o atrial e dem&#234;ncia em participantes do S&#227;o Paulo Ageing &amp; Health. M&#201;TODOS: O S&#227;o Paulo Ageing &amp; Health &#233; um estudo transversal, de base populacional, de idosos residentes em um uma regi&#227;o de baixa renda da cidade de S&#227;o Paulo, Brasil. Diagn&#243;stico de dem&#234;ncia foi realizado de acordo com o protocolo do grupo 10/66, com base em crit&#233;rios do Manual de Diagn&#243;stico e Estat&#237;stica das Perturba&#231;&#245;es Mentais (DSM-IV). O diagn&#243;stico de fibrila&#231;&#227;o atrial foi feito por eletrocardiograma de 12 deriva&#231;&#245;es, avaliado por dois cardiologistas. Dados demogr&#225;ficos e de fatores de risco cardiovasculares tamb&#233;m foram obtidos. RESULTADOS: A dem&#234;ncia foi diagnosticada em 66 (4,3%) e fibrila&#231;&#227;o atrial em 36 (2,4%) de 1.524 participantes com um eletrocardiograma v&#225;lido. A raz&#227;o de chances bruta para dem&#234;ncia em participantes com fibrila&#231;&#227;o atrial foi 2,8 (intervalo de confian&#231;a [IC] 95%: 1,0-8,1; p = 0,06) em compara&#231;&#227;o com indiv&#237;duos sem fibrila&#231;&#227;o atrial. Rela&#231;&#227;o positiva foi encontrada em mulheres (RC 4,2; IC 95%: 1,2-15,1; p = 0,03). Ap&#243;s ajuste para idade, no entanto, essa associa&#231;&#227;o tornou-se n&#227;o significativa (RC 2,2, IC 95%: 0,6-8,9; p = 0,26). CONCLUS&#195;O: N&#227;o houve associa&#231;&#227;o independente entre a fibrila&#231;&#227;o atrial e dem&#234;ncia nessa amostra. A preval&#234;ncia da fibrila&#231;&#227;o atrial pode ser baixa nesta popula&#231;&#227;o em virtude da mortalidade cardiovascular prematura.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Fibrila&#231;&#227;o atrial</kwd>
        <kwd>doen&#231;a cardiovascular</kwd>
        <kwd>dem&#234;ncia</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>16</day>
        <month>11</month>
        <year>2012</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>
      <bold>Fibrila&#231;&#227;o atrial e dem&#234;ncia: resultados do S&#227;o Paulo ageing &amp; health study</bold>
    </p>
    <p>
      <bold>Liz Andrea Kawabata-Yoshihara<sup>I</sup>; M&#225;rcia Scazufca<sup>II, III</sup>; Itamar de Souza Santos<sup>II</sup>; Aristarcho Whitaker<sup>I</sup>; Vitor S&#233;rgio Kawabata<sup>I</sup>; Isabela Martins Bense&#241;or<sup>I, II</sup>; Paulo Rossi Menezes<sup>II</sup>; Paulo Andrade Lotufo<sup>I, II</sup></bold>
    </p>
    <p><sup>I</sup>Hospital Universit&#225;rio da Universidade de S&#227;o Paulo, S&#227;o Paulo, SP &#150; Brasil </p>
    <p><sup>II</sup>Faculdade de Medicina da Universidade de S&#227;o Paulo, S&#227;o Paulo, SP &#150; Brasil </p>
    <p><sup>III</sup>Hospital das Cl&#237;nicas da Faculdade de Medicina da Universidade de S&#227;o Paulo, S&#227;o Paulo, SP &#150; Brasil</p>
    <p>
      <xref ref-type="corresp" rid="nt">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>FUNDAMENTO: </bold> A fibrila&#231;&#227;o atrial &#233; um fator de risco controverso para dem&#234;ncia. </p>
    <p><bold>OBJETIVO: </bold> O objetivo deste estudo &#233; avaliar a associa&#231;&#227;o entre fibrila&#231;&#227;o atrial e dem&#234;ncia em participantes do S&#227;o Paulo Ageing &amp; Health. </p>
    <p><bold>M&#201;TODOS: </bold> O S&#227;o Paulo Ageing &amp; Health &#233; um estudo transversal, de base populacional, de idosos residentes em um uma regi&#227;o de baixa renda da cidade de S&#227;o Paulo, Brasil. Diagn&#243;stico de dem&#234;ncia foi realizado de acordo com o protocolo do grupo 10/66, com base em crit&#233;rios do Manual de Diagn&#243;stico e Estat&#237;stica das Perturba&#231;&#245;es Mentais (DSM-IV). O diagn&#243;stico de fibrila&#231;&#227;o atrial foi feito por eletrocardiograma de 12 deriva&#231;&#245;es, avaliado por dois cardiologistas. Dados demogr&#225;ficos e de fatores de risco cardiovasculares tamb&#233;m foram obtidos. </p>
    <p><bold>RESULTADOS: </bold> A dem&#234;ncia foi diagnosticada em 66 (4,3%) e fibrila&#231;&#227;o atrial em 36 (2,4%) de 1.524 participantes com um eletrocardiograma v&#225;lido. A raz&#227;o de chances bruta para dem&#234;ncia em participantes com fibrila&#231;&#227;o atrial foi 2,8 (intervalo de confian&#231;a [IC] 95%: 1,0-8,1; p = 0,06) em compara&#231;&#227;o com indiv&#237;duos sem fibrila&#231;&#227;o atrial. Rela&#231;&#227;o positiva foi encontrada em mulheres (RC 4,2; IC 95%: 1,2-15,1; p = 0,03). Ap&#243;s ajuste para idade, no entanto, essa associa&#231;&#227;o tornou-se n&#227;o significativa (RC 2,2, IC 95%: 0,6-8,9; p = 0,26). </p>
    <p><bold>CONCLUS&#195;O: </bold> N&#227;o houve associa&#231;&#227;o independente entre a fibrila&#231;&#227;o atrial e dem&#234;ncia nessa amostra. A preval&#234;ncia da fibrila&#231;&#227;o atrial pode ser baixa nesta popula&#231;&#227;o em virtude da mortalidade cardiovascular prematura. </p>
    <p><bold>Palavras-chave: </bold> Fibrila&#231;&#227;o atrial; doen&#231;a cardiovascular; dem&#234;ncia.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>Estima-se que a maioria das pessoas com dem&#234;ncia viva em pa&#237;ses de baixa e m&#233;dia renda<sup>1</sup>, no entanto, h&#225; muito poucos dados sobre fatores de risco para dem&#234;ncia nessas popula&#231;&#245;es<sup>2</sup>.</p>
    <p>O papel da fibrila&#231;&#227;o atrial (FA) como fator de risco para a dem&#234;ncia &#233; ainda objeto de intenso debate e resultados conflitantes. Pelo fato de a dem&#234;ncia poder ser de origem vascular (mesmo na aus&#234;ncia de acidente vascular cerebral documentado), alguns estudos avaliaram um poss&#237;vel papel de FA no desenvolvimento de dem&#234;ncia. O estudo Rotterdam<sup>3</sup> mostrou uma associa&#231;&#227;o entre FA e risco de dem&#234;ncia e/ou pior fun&#231;&#227;o cognitiva, com um risco relativo (RR) de 2,3 e intervalo de confian&#231;a de 95% (IC95%) de 1,4-3,7. Tilvis et al. encontraram uma associa&#231;&#227;o positiva entre a FA e decl&#237;nio cognitivo em uma amostra populacional de 650 indiv&#237;duos com 75 anos ou mais depois de 5 anos (mas n&#227;o depois de 10 anos) de seguimento<sup>4</sup>. Forti et al.<sup>5</sup>, estudando indiv&#237;duos com dist&#250;rbio cognitivo leve (DCL), encontraram uma taxa de convers&#227;o para dem&#234;ncia de 10,5/100 pessoas-ano. A presen&#231;a de FA nesse estudo foi associada com um risco 4,6 vezes maior de evolu&#231;&#227;o para dem&#234;ncia (IC95%: 1,7-12,5).</p>
    <p>Por outro lado, Park et al. n&#227;o encontraram diferen&#231;as na fun&#231;&#227;o cognitiva de indiv&#237;duos com FA e 60 anos de idade ou mais no estudo <italic>Cognition and Atrial Fibrillation Evaluation</italic> (Cafe), seja na entrada do estudo<sup>6</sup> ou ap&#243;s tr&#234;s anos de seguimento.<sup>7</sup> O estudo Vantaa 85+[8] incluiu residentes com 85 anos ou mais velhos (n = 553) e n&#227;o encontrou nenhuma diferen&#231;a na frequ&#234;ncia de dem&#234;ncia em indiv&#237;duos com e sem FA no in&#237;cio do estudo (41,0% <italic>versus</italic> 38,1%)<sup>8</sup>. Da mesma forma, n&#227;o houve diferen&#231;a na incid&#234;ncia de dem&#234;ncia em indiv&#237;duos com FA ap&#243;s um seguimento m&#233;dio de 3,5 anos.</p>
    <p>Os dados sobre o tema s&#227;o, portanto, conflitantes na literatura. Apesar de recente publica&#231;&#227;o sobre a preval&#234;ncia de FA em idosos<sup>9</sup>, n&#227;o h&#225; informa&#231;&#245;es sobre a associa&#231;&#227;o entre FA e dem&#234;ncia na popula&#231;&#227;o brasileira. O objetivo deste estudo foi avaliar uma poss&#237;vel associa&#231;&#227;o entre a FA e dem&#234;ncia em uma popula&#231;&#227;o de idosos residentes em um bairro de baixa renda na &#225;rea metropolitana da cidade de S&#227;o Paulo.</p>
    <p>
      <bold>M&#233;todos</bold>
    </p>
    <p>O S&#227;o Paulo Ageing &amp; Health Study (SPAH) consistiu em uma primeira fase de coorte transversal, com base populacional, realizada com todos os residentes de uma &#225;rea de baixo n&#237;vel socioecon&#244;mico em S&#227;o Paulo, Brasil, com 65 anos ou mais. O principal objetivo do SPAH foi avaliar a preval&#234;ncia de dem&#234;ncia, como parte de um programa de colabora&#231;&#227;o desenvolvido pelo 10/66 <italic>Dementia Research Group</italic>. O protocolo do estudo est&#225; detalhado em outros artigos<sup>10,11</sup>. Um subestudo abordando os padr&#245;es de eletrocardiograma (ECG) nessa popula&#231;&#227;o foi publicado anteriormente<sup>9</sup>.</p>
    <p>
      <bold>Popula&#231;&#227;o e amostra</bold>
    </p>
    <p>SPAH focou em todos os residentes com 65 anos ou mais moradores de 66 setores censit&#225;rios (menores &#225;reas administrativas) no bairro do Butant&#227;. Os setores selecionados eram aqueles com pior n&#237;vel socioecon&#244;mico da &#225;rea, incluindo favelas. A estrat&#233;gia de identifica&#231;&#227;o e recrutamento foi feita com visitas casa a casa a todas as fam&#237;lias. A elegibilidade foi baseada exclusivamente na idade do indiv&#237;duo no momento do recrutamento. Com exce&#231;&#227;o dos indiv&#237;duos institucionalizados que n&#227;o foram inclu&#237;dos, todos foram convidados a participar do estudo. Os moradores de todos os setores censit&#225;rios que preenchiam os crit&#233;rios de inclus&#227;o para o estudo foram convidados a participar.</p>
    <p>Dos 2.266 participantes eleg&#237;veis com 65 anos ou mais, 2.072 (91,4%) consentiram em participar e foram avaliados para dem&#234;ncia por profissionais especialistas em sa&#250;de mental. A investiga&#231;&#227;o de altera&#231;&#245;es no ECG come&#231;ou quando o recrutamento do SPAH j&#225; estava em andamento. Para minimizar a influ&#234;ncia do tempo decorrido desde o in&#237;cio da coleta de dados e grava&#231;&#227;o de ECG, indiv&#237;duos nos quais uma grava&#231;&#227;o de ECG n&#227;o foi obtida at&#233; um ano ap&#243;s a inclus&#227;o SPAH foram exclu&#237;dos da an&#225;lise. As raz&#245;es para a exclus&#227;o s&#227;o mostradas na <xref ref-type="fig" rid="en_0312fig01">Figura 1</xref>. Casos exclu&#237;dos da an&#225;lise n&#227;o diferiram significativamente daqueles com ECG v&#225;lido de acordo com idade, sexo ou ra&#231;a.</p>
    <p content-type="asset">
      <fig id="en_0312fig01">
        <graphic xlink:href="1678-4170-abc-99-06-1108-00106-gf01.jpg"/></fig>
    </p>
    <p>
      <bold>Protocolo SPAH</bold>
    </p>
    <p>Os indiv&#237;duos que concordaram em participar foram convidados para uma entrevista de 90 minutos realizada no domic&#237;lio dos participantes cerca de uma semana ap&#243;s o recrutamento por oito trabalhadores de sa&#250;de mental treinados. Para cada participante, um informante tamb&#233;m foi identificado<sup>10</sup>. Informa&#231;&#245;es sobre ra&#231;a, idade, escolaridade, estado socioecon&#244;mico, hist&#243;rico m&#233;dico, fun&#231;&#227;o cognitiva e funcionalidade foram coletadas usando um question&#225;rio padronizado. Um auxiliar de enfermagem realizava, em domic&#237;lio, as avalia&#231;&#245;es antropom&#233;tricas e de press&#227;o arterial de 2 a 15 dias ap&#243;s a entrevista de avalia&#231;&#227;o. Uma amostra de sangue venoso era obtida em jejum.</p>
    <p>
      <bold>Diagn&#243;stico de dem&#234;ncia</bold>
    </p>
    <p>O diagn&#243;stico de dem&#234;ncia foi fundamentado nos crit&#233;rios do DSM-IV<sup>12</sup>. A presen&#231;a de dem&#234;ncia foi avaliada com um instrumento diagn&#243;stico desenvolvido pelo 10/66 <italic>Dementia Research Group</italic> e validado para uso em estudos de base populacional em pa&#237;ses com baixa e m&#233;dia renda<sup>13</sup>. Informa&#231;&#245;es sobre comprometimento cognitivo, com uma avalia&#231;&#227;o detalhada do in&#237;cio e da evolu&#231;&#227;o da s&#237;ndrome demencial, foram coletadas dos participantes e seus informantes. As ferramentas de diagn&#243;stico aplicadas ao participante inclu&#237;ram o <italic>Community Screening Interveiw for Dementia </italic>(CSI-D)<sup>14</sup>, uma vers&#227;o modificada da tarefa de aprendizagem de dez palavras com evoca&#231;&#227;o tardia e da tarefa de flu&#234;ncia verbal de nomea&#231;&#227;o animal do <italic>Consortium to Establish a Registry for Alzheimer's Disease </italic>(CERAD)<sup>15</sup>, uma vers&#227;o voltada para aplica&#231;&#227;o comunit&#225;ria do <italic>Geriatric Mental State</italic> (GMS), uma entrevista semiestruturada cl&#237;nica para avalia&#231;&#227;o do estado mental<sup>16,17</sup> e uma avalia&#231;&#227;o neurol&#243;gica estruturada para verificar a presen&#231;a de sinais de lateraliza&#231;&#227;o, parkinsonismo, ataxia, apraxia, e reflexos primitivos. A entrevista com informantes constou de perguntas sobre o desempenho funcional e cognitivo do participante fundamentado no CSI-D e um breve hist&#243;rico do funcionamento e decl&#237;nio cognitivo do participante com base no <italic>History and Aetiology Schedule Dementia Diagnosis and Subtype </italic>(HAS-DDS)<sup>18</sup>, aplicada quando o CSI-D apontava para a presen&#231;a de disfun&#231;&#227;o. O HAS-DDS tamb&#233;m foi utilizado para definir os subtipos de dem&#234;ncia, tais como a doen&#231;a de Alzheimer, dem&#234;ncia vascular ou dem&#234;ncia mista. Esta &#250;ltima era definida como a presen&#231;a de caracter&#237;sticas de ambos os subtipos anteriores ou hist&#243;ria de parkinsonismo.</p>
    <p>
      <bold>Diagn&#243;stico de fibrila&#231;&#227;o atrial</bold>
    </p>
    <p>O eletrocardiograma de repouso de 12 deriva&#231;&#245;es foi obtido em domic&#237;lio. Os registros foram analisados de forma independente por dois cardiologistas (AW e VSK), utilizando o c&#243;digo de Minnesota. Houve concord&#226;ncia no diagn&#243;stico dos ECGs em 92,9% dos casos. Nos casos de discord&#226;ncia, uma nova an&#225;lise era feita por ambos. Em todos os casos foi alcan&#231;ado consenso.</p>
    <p>
      <bold>Outras vari&#225;veis</bold>
    </p>
    <p>As vari&#225;veis idade, grau de escolaridade e renda mensal foram categorizadas para an&#225;lise. Hipertens&#227;o arterial foi definida como hist&#243;ria m&#233;dica positiva para hipertens&#227;o arterial, tratamento atual para hipertens&#227;o arterial, ou press&#227;o arterial sist&#243;lica <underline>&gt;</underline> 140 mmHg e/ou press&#227;o arterial diast&#243;lica <underline>&gt;</underline> 90 mmHg na visita do estudo. Diabetes <italic>mellitus</italic> foi definida como hist&#243;ria m&#233;dica positiva para diabetes, uso atual de insulina ou hipoglicemiante oral, ou um n&#237;vel de glicemia de jejum <underline>&gt;</underline> 126 mg / dl.</p>
    <p>
      <bold>Considera&#231;&#245;es &#233;ticas</bold>
    </p>
    <p>O estudo foi aprovado no Comit&#234; de &#201;tica em Pesquisa do Hospital Universit&#225;rio e todos os participantes assinaram documento de consentimento informado. Nos casos em que eles eram incapazes de fornecer consentimento por incapacidades f&#237;sicas ou mentais, era obtida uma vers&#227;o do consentimento assinada pelo informante. Quando o participante era analfabeto, a folha de informa&#231;&#227;o e respectivo consentimento eram lidos em voz alta e adquiria-se um consentimento verbal testemunhado.</p>
    <p>
      <bold>An&#225;lise estat&#237;stica</bold>
    </p>
    <p>Foi realizada dupla entrada de dados, usando o programa Epidata 3.0, com valida&#231;&#227;o para identificar e corrigir erros de digita&#231;&#227;o. Os dados foram analisados utilizando o programa SPSS 16.0. Qui-quadrado de Pearson e teste exato de Fisher, conforme apropriado, foram utilizados para comparar vari&#225;veis categ&#243;ricas. Tamb&#233;m foi realizada regress&#227;o log&#237;stica bin&#225;ria para avaliar a rela&#231;&#227;o entre a presen&#231;a de FA e o diagn&#243;stico de dem&#234;ncia (todos os tipos), doen&#231;a de Alzheimer e dem&#234;ncia vascular. Foram utilizados tr&#234;s modelos de inclus&#227;o para essas an&#225;lises. No Modelo 1, todos os participantes com ECG v&#225;lidos foram inclu&#237;dos. No Modelo 2, foram exclu&#237;dos os indiv&#237;duos sem FA no ECG, mas que estavam em uso de amiodarona e/ou varfarina uma vez que estas podem ser evid&#234;ncias de fibrila&#231;&#227;o atrial parox&#237;stica. No Modelo 3, consideramos o subgrupo de participantes que recebem amiodarona e/ou varfarina como indiv&#237;duos com FA. Os dados foram analisados inicialmente sem ajuste e, ap&#243;s, ajustados para idade. S&#227;o apresentadas as estimativas pontuais e seus respectivos IC95%. P-valores inferiores a 0,05 foram considerados estatisticamente significativos.</p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>Foram obtidos registros eletrocardiogr&#225;ficos v&#225;lidos de 1.524 (73,6%) indiv&#237;duos. A <xref ref-type="table" rid="en_0312tab01">Tabela 1</xref> mostra as caracter&#237;sticas de entrada dos participantes SPAH com ECG v&#225;lido. A FA foi encontrada em 37 (2,4%) deles, sendo 19/603 (3,2%) homens e 18/921 (2,0%) mulheres. Os indiv&#237;duos com FA eram mais velhos do que aqueles sem FA (m&#233;dia de idade 77,7 &#177; 7,9 anos <italic>versus </italic>72,1 &#177; 6,2 anos, p &lt; 0,01). Dos indiv&#237;duos com FA, 19 (51,4%) receberam terapia antiplaquet&#225;ria ou anticoagulante: 10 (27,0%) receberam aspirina, 8 (21,6%) receberam varfarina e 1 (2,7%) recebeu ticlopidina. Quinze (40,5%) indiv&#237;duos receberam medica&#231;&#245;es utilizadas comumente para controle do ritmo ou de frequ&#234;ncia na FA. Oito (21,6%) receberam digoxina, 3 (8,1%) receberam betabloqueadores, 2 (5,4%) receberam amiodarona, 1 (2,7%) recebeu bloqueadores do canal de c&#225;lcio, e 1 (2,7%) recebeu betabloqueadores e bloqueadores dos canais de c&#225;lcio.</p>
    <p content-type="asset">
      <table-wrap id="en_0312tab01">
        <graphic xlink:href="1678-4170-abc-99-06-1108-00106-gt01.jpg"/></table-wrap>
    </p>
    <p>Dentre os sujeitos com ECG avaliado, 66 (4,3%) tinham um diagn&#243;stico de dem&#234;ncia &#150; 44 de 921 eram mulheres (4,8%) e 22 de 603 eram homens (3,6%). Neste estudo ancilar, 25 (37,9%) dos indiv&#237;duos tinham doen&#231;a de Alzheimer, 25 (37,9%) tinham dem&#234;ncia vascular e 16 (24,2%) tinham dem&#234;ncia mista. A <xref ref-type="table" rid="en_0312tab02">Tabela 2</xref> mostra a raz&#227;o de chances (bruta e ajustada por idade) para dem&#234;ncia (todos os subtipos), doen&#231;a de Alzheimer e dem&#234;ncia vascular comparando indiv&#237;duos com e sem FA (Modelo 1). Os dados s&#227;o estratificados por sexo. Ao serem exclu&#237;dos os participantes que n&#227;o apresentaram FA na grava&#231;&#227;o do ECG, mas que utilizavam amiodarona e/ou varfarina (Modelo 2) no momento da avalia&#231;&#227;o, os resultados n&#227;o se alteraram. Quando consideramos os participantes em uso de amiodarona e/ou varfarina no tratamento como indiv&#237;duos com FA (Modelo 3), nenhuma rela&#231;&#227;o alcan&#231;ou signific&#226;ncia estat&#237;stica.</p>
    <p content-type="asset">
      <table-wrap id="en_0312tab02">
        <graphic xlink:href="1678-4170-abc-99-06-1108-00106-gt02.jpg"/></table-wrap>
    </p>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>FA e dem&#234;ncia s&#227;o doen&#231;as cr&#244;nicas associadas &#224; alta morbidade, mortalidade e incapacita&#231;&#227;o<sup>19-21</sup>. Em nosso estudo, encontramos uma associa&#231;&#227;o entre FA e dem&#234;ncia em mulheres, por&#233;m essa associa&#231;&#227;o desapareceu ap&#243;s ajuste para idade, sugerindo que n&#227;o h&#225; rela&#231;&#227;o independente entre essas duas condi&#231;&#245;es. Nenhuma associa&#231;&#227;o foi encontrada para os homens ou ao serem analisados os subtipos de dem&#234;ncia.</p>
    <p>&#201; dif&#237;cil estabelecer compara&#231;&#245;es diretas entre os estudos que abordam a rela&#231;&#227;o entre a FA e dem&#234;ncia em virtude de diferen&#231;as metodol&#243;gicas. Um dos principais entraves &#233; o fato de que os instrumentos utilizados para diagnosticar a dem&#234;ncia e/ou comprometimento cognitivo variam muito. Em popula&#231;&#245;es de baixa renda, as diferen&#231;as educacionais e culturais tamb&#233;m podem influenciar os resultados<sup>22</sup>. Neste estudo, de base populacional, foi utilizado um algoritmo composto por v&#225;rias ferramentas de diagn&#243;stico, com base em crit&#233;rios do DSM-IV e corroborado por estudos anteriores<sup>13</sup>, desenvolvido e validado especificamente para o diagn&#243;stico de dem&#234;ncia em popula&#231;&#245;es de baixa e m&#233;dia renda.</p>
    <p>Uma vez que este &#233; um tema de debate na literatura m&#233;dica, e dados de estudos anteriores levaram a conclus&#245;es conflitantes, &#233; importante apontar as raz&#245;es que podem ser respons&#225;veis por nossos resultados negativos e os resultados positivos de outros grupos. Em primeiro lugar, este &#233; um estudo de base populacional. Alguns autores encontraram um resultado positivo em amostras de indiv&#237;duos com dist&#250;rbio cognitivo leve<sup>5,23</sup>. Numa amostra com essas caracter&#237;sticas, uma maior convers&#227;o para dem&#234;ncia &#233; esperada, favorecendo resultados positivos. Al&#233;m disso, supondo que uma rela&#231;&#227;o verdadeira entre FA e dem&#234;ncia exista apenas em um subgrupo de indiv&#237;duos, esta abordagem pode "selecionar" indiv&#237;duos nos quais esse processo j&#225; come&#231;ou, o que tamb&#233;m favorece um resultado positivo. Estender esses achados a toda a popula&#231;&#227;o pode levar a conclus&#245;es equivocadas.</p>
    <p>Nossos resultados contrastam com os resultados do estudo Rotterdam<sup>3</sup>, que incluiu indiv&#237;duos mais jovens (eram inclu&#237;dos a partir de 55 anos). Os resultados apontaram para uma forte associa&#231;&#227;o entre a FA e dem&#234;ncia em indiv&#237;duos mais jovens (idade &lt; 75 anos). Essa &#233; uma poss&#237;vel explica&#231;&#227;o para as diferen&#231;as observadas em seu estudo comparado com o nosso. Com o avan&#231;o da idade, outros mecanismos de doen&#231;a podem se tornar proeminentes e, com isso, enfraquecer uma associa&#231;&#227;o com FA. Em uma amostra de baixa renda, como no presente estudo, tamb&#233;m &#233; esperado que um vi&#233;s de sobreviv&#234;ncia em virtude de mortes prematuras, por todas as causas<sup>24</sup> ou por doen&#231;a cardiovascular<sup>25</sup>. Isso pode ser pelo menos parcialmente respons&#225;vel pelas menores taxas de FA observada em nosso estudo (preval&#234;ncia de 2,0% em mulheres e 3,2% em homens), comparado ao <italic>Cardiovascular Health Study</italic> (4,8% em mulheres e 6,2% em homens)<sup>26 </sup>e o <italic>Rotterdam Study</italic> (7,5% em mulheres e 9,7% em homens)<sup>27</sup>. Essa menor preval&#234;ncia pode dificultar a observa&#231;&#227;o de uma associa&#231;&#227;o entre FA e dem&#234;ncia.</p>
    <p>Nosso estudo tem algumas limita&#231;&#245;es. O pequeno n&#250;mero de indiv&#237;duos com FA e dem&#234;ncia concomitante prejudica a an&#225;lise por subtipos. Um estudo transversal n&#227;o &#233; suficiente para estabelecer uma rela&#231;&#227;o causal entre duas condi&#231;&#245;es. No entanto, a aus&#234;ncia de associa&#231;&#227;o nesse tipo de estudo indica que uma rela&#231;&#227;o causal realmente n&#227;o existe. O registro &#250;nico de ECG, utilizado para o diagn&#243;stico de FA, n&#227;o permite o diagn&#243;stico acurado de FA parox&#237;stica e n&#227;o identifica indiv&#237;duos tratados com sucesso com as estrat&#233;gias de tratamento por controle de ritmo. No entanto, a exclus&#227;o dos participantes com ritmo sinusal normal que estavam recebendo tratamento potencialmente dirigida a FA parox&#237;stica (Modelo 2), bem como consider&#225;-los como pacientes com FA (Modelo 3), n&#227;o alterou significativamente os resultados.</p>
    <p>
      <bold>Conclus&#227;o</bold>
    </p>
    <p>Concluindo, nosso estudo n&#227;o encontrou uma associa&#231;&#227;o independente entre a FA e dem&#234;ncia em uma amostra de base populacional vivendo em uma &#225;rea de baixa renda em S&#227;o Paulo, Brasil. A preval&#234;ncia da FA pode ser baixa nesta popula&#231;&#227;o devido &#224; morte prematura, em especial por doen&#231;a cardiovascular.</p>
    <p>
      <bold>Agradecimentos</bold>
    </p>
    <p>Este estudo foi financiado pelo Wellcome Trust e pela FAPESP (Funda&#231;&#227;o de Apoio &#224; Pesquisa do Estado de S&#227;o Paulo).</p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>O presente estudo foi financiado por FAPESP e Wellcome Trust.</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>Este artigo &#233; parte de tese de doutorado de Liz Andrea Kawabata-Yoshihara pela Faculdade de Medicina da USP.</p>
    <p>
      <fn id="nt" fn-type="corresp">
        <p>Correspond&#234;ncia:</p>
        <p>Itamar de Souza Santos </p>
        <p> Centro de Pesquisa Cl&#237;nica e Epidemiol&#243;gica </p>
        <p> Av. Prof. Lineu Prestes, 2565, Cidade Universit&#225;ria </p>
        <p> CEP 05508-000, S&#227;o Paulo, SP &#150; Brasil </p>
        <p> E-mail: </p>
        <p><email xlink:href="itamarss@usp.br">itamarss@usp.br</email>, </p>
        <p>
          <email xlink:href="itamarss@gmail.com">itamarss@gmail.com</email>
        </p>
      </fn>
    </p>
    <p>Artigo recebido em 10/04/12 </p>
    <p> revisado em 12/04/12 </p>
    <p> aceito em 01/08/12</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <mixed-citation>1. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366(9503):2112-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Global prevalence of dementia: a Delphi consensus study</article-title>
          <source>Lancet</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>2112</fpage>
          <lpage>7</lpage>
          <issue>9503</issue>
          <volume>366</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ferri</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Prince</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Brayne</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Brodaty</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Fratiglioni</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ganguli</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <mixed-citation>2. Newman AB, Fritzpatrick AL, Lopez O, Jackson S, Lyketsos C, Jagust W, et al. Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J Am Geriatr Soc. 2005;53(7):1101-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort</article-title>
          <source>J Am Geriatr Soc</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>1101</fpage>
          <lpage>7</lpage>
          <issue>7</issue>
          <volume>53</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Newman</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Fritzpatrick</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Lopez</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Jackson</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lyketsos</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Jagust</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <mixed-citation>3. Ott A, Breteler M, de Bruyne M, Harskamp F, Grobbee DE, Hofman A. Atrial fibrillation and dementia in a population-based study: The Rotterdam Study. Stroke. 1997;28(2):316-21.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Atrial fibrillation and dementia in a population-based study: The Rotterdam Study</article-title>
          <source>Stroke</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>316</fpage>
          <lpage>21</lpage>
          <issue>2</issue>
          <volume>28</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ott</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Breteler</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>de Bruyne</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Harskamp</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Grobbee</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Hofman</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <mixed-citation>4. Tilvis RJ, Kahonen-Vare MH, Jolkkonen J, Valvanne J, Pitkala KH, Strandberg TE. Predictors of cognitive decline and mortality of aged people over a 10-year period. J Gerontol. 2004;59(3):268-74.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Predictors of cognitive decline and mortality of aged people over a 10-year period</article-title>
          <source>J Gerontol</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>268</fpage>
          <lpage>74</lpage>
          <issue>3</issue>
          <volume>59</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Tilvis</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Kahonen-Vare</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Jolkkonen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Valvanne</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pitkala</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>Strandberg</surname>
              <given-names>TE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <mixed-citation>5. Forti P, Maioli F, Pisacane N, Rietti E, Montesi F, Ravaglia G. Atrial fibrillation and risk of dementia in non-demented elderly subjects with and without mild cognitive impairment. Neurol R. 2006;28(6):625-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Atrial fibrillation and risk of dementia in non-demented elderly subjects with and without mild cognitive impairment</article-title>
          <source>Neurol R</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>625</fpage>
          <lpage>9</lpage>
          <issue>6</issue>
          <volume>28</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Forti</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Maioli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Pisacane</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Rietti</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Montesi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ravaglia</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <mixed-citation>6. Park H, Hildreth A, Thomson R, O'Connell J. Non-valvular atrial fibrillation and cognitive function&#8211;baseline results of a longitudinal cohort study. Age Ageing. 2005;34(4):392-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Non-valvular atrial fibrillation and cognitive function-baseline results of a longitudinal cohort study</article-title>
          <source>Age Ageing</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>392</fpage>
          <lpage>5</lpage>
          <issue>4</issue>
          <volume>34</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hildreth</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Thomson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>O'Connell</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <mixed-citation>7. Park H, Hildreth A, Thomson R, O'Connell J. Non-valvular atrial fibrillation and cognitive decline: a longitudinal cohort study. Age Ageing. 2007;36(2):157-63.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Non-valvular atrial fibrillation and cognitive decline: a longitudinal cohort study</article-title>
          <source>Age Ageing</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>157</fpage>
          <lpage>63</lpage>
          <issue>2</issue>
          <volume>36</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hildreth</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Thomson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>O'Connell</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <mixed-citation>8. Rastas S, Verkkoniemi A, Polvikoski T, Juva K, Niinist&#246; L, Mattila K, et al. Atrial fibrillation, stroke, and cognition: a longitudinal population-based study of people aged 85 and older. Stroke. 2007;38(5):1454-60.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Atrial fibrillation, stroke, and cognition: a longitudinal population-based study of people aged 85 and older</article-title>
          <source>Stroke</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>1454</fpage>
          <lpage>60</lpage>
          <issue>5</issue>
          <volume>38</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rastas</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Verkkoniemi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Polvikoski</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Juva</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Niinist&#246;</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Mattila</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <mixed-citation>9. Kawabata-Yoshihara LA, Bense&#241;or IM, Kawabata VS, Menezes PR, Scazufca M, Lotufo PA. Prevalence of electrocardiographic findings in elderly individuals: the S&#227;o Paulo Ageing &amp; Health Study. Arq Bras Cardiol. 2009;93(6):602-7.</mixed-citation>
        <element-citation publication-type="other">
          <person-group person-group-type="author">
            <name>
              <surname>Kawabata-Yoshihara</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Bense&#241;or</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Kawabata</surname>
              <given-names>VS</given-names>
            </name>
            <name>
              <surname>Menezes</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Scazufca</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lotufo</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <mixed-citation>10. Scazufca M, Menezes PR, Vallada HP, Crepaldi AL, Pastor-Valero M, Coutinho LMS, et al. High prevalence of dementia among older adults from poor socioeconomic backgrounds in S&#227;o Paulo, Brazil. Int Psychogeriatr. 2008;20(2):394-405.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>High prevalence of dementia among older adults from poor socioeconomic backgrounds in S&#227;o Paulo, Brazil</article-title>
          <source>Int Psychogeriatr</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>394</fpage>
          <lpage>405</lpage>
          <issue>2</issue>
          <volume>20</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Scazufca</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Menezes</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Vallada</surname>
              <given-names>HP</given-names>
            </name>
            <name>
              <surname>Crepaldi</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Pastor-Valero</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Coutinho</surname>
              <given-names>LMS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <mixed-citation>11. Santos IS, Scazufca M, Menezes PR, Lotufo PA, Bense&#241;or IM. Anemia and dementia among the elderly: the S&#227;o Paulo Ageing &amp; Health Study. Int Psychogeriatr. 2012;24(1):74-81.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Anemia and dementia among the elderly: the S&#227;o Paulo Ageing &amp; Health Study</article-title>
          <source>Int Psychogeriatr</source>
          <date>
            <year>2012</year>
          </date>
          <fpage>74</fpage>
          <lpage>81</lpage>
          <issue>1</issue>
          <volume>24</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Santos</surname>
              <given-names>IS</given-names>
            </name>
            <name>
              <surname>Scazufca</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Menezes</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Lotufo</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Bense&#241;or</surname>
              <given-names>IM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <mixed-citation>12. American Psychiatry Association. Diagnostic and Statistical Manual of Mental Disorders. 4. Washington: American Psychiatry Association; 1994.</mixed-citation>
        <element-citation publication-type="book">
          <source>Diagnostic and Statistical Manual of Mental Disorders.4</source>
          <date>
            <year>1994</year>
          </date>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <mixed-citation>13. Prince M. Methodological issues for population-based research into dementia in developing countries: a position paper from the 10/66 Dementia Research Group. Int J Geriatr Psychiatry. 2000;15(1):21-30.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Methodological issues for population-based research into dementia in developing countries: a position paper from the 10/66 Dementia Research Group</article-title>
          <source>Int J Geriatr Psychiatry</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>21</fpage>
          <lpage>30</lpage>
          <issue>1</issue>
          <volume>15</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Prince</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <mixed-citation>14. Hall KS, Gao S, Emsley CL, Ogunniyi AO, Morgan O, Hendrie HC. Community screening interview for dementia (CSI'D'); performance in five disparate study sites. Int J Geriatr Psychiatry. 2000;15(6):521-31.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Community screening interview for dementia (CSI'D'); performance in five disparate study sites</article-title>
          <source>Int J Geriatr Psychiatry</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>521</fpage>
          <lpage>31</lpage>
          <issue>6</issue>
          <volume>15</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hall</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Emsley</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Ogunniyi</surname>
              <given-names>AO</given-names>
            </name>
            <name>
              <surname>Morgan</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Hendrie</surname>
              <given-names>HC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <mixed-citation>15. Welsh KA, Butters N, Mohs RC, <bold>Beekly D, Edland S, Fillenbaum G, </bold>et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology. 1994;44(4) 609-14.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The consortium to establish a registry for Alzheimer's disease (CERAD). Part V. A normative study of the neuropsychological battery</article-title>
          <source>Neurology</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>609</fpage>
          <lpage>14</lpage>
          <issue>4</issue>
          <volume>44</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Welsh</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Butters</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Mohs</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Beekly</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Edland</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fillenbaum</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <mixed-citation>16. Copeland JR, Dewey ME, Griffiths-Jones HM. A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT. Psychol Med. 1986;16(1):89-99.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT</article-title>
          <source>Psychol Med</source>
          <date>
            <year>1986</year>
          </date>
          <fpage>89</fpage>
          <lpage>99</lpage>
          <issue>1</issue>
          <volume>16</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Copeland</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Dewey</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Griffiths-Jones</surname>
              <given-names>HM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <mixed-citation>17. Prince M, Acosta D, Chiu H, Copeland J, Dewey M, Scazufca M, et al. Effects of education and culture on the validity of the Geriatric Mental State and its AGECAT algorithm. Br J Psychiatry. 2004;185:429-36.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effects of education and culture on the validity of the Geriatric Mental State and its AGECAT algorithm</article-title>
          <source>Br J Psychiatry</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>429</fpage>
          <lpage>36</lpage>
          <volume>185</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Prince</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Acosta</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Chiu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Copeland</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Dewey</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Scazufca</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <mixed-citation>18. Dewey ME, Copeland JRM. Diagnosis of dementia from the history and aetiology schedule. Int J Geriatr Psychiatry. 2001;16(9):912-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Diagnosis of dementia from the history and aetiology schedule</article-title>
          <source>Int J Geriatr Psychiatry</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>912</fpage>
          <lpage>7</lpage>
          <issue>9</issue>
          <volume>16</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Dewey</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Copeland</surname>
              <given-names>JRM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <mixed-citation>19. Ag&#252;erro-Torres H, Fratiglioni L, Guo Z, Viitanen M, Winblad B. Mortality from dementia in advanced age: a 5-year follow-up study of incident dementia cases. J Clin Epidemiol. 1999;52(8):737-43.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Mortality from dementia in advanced age: a 5-year follow-up study of incident dementia cases</article-title>
          <source>J Clin Epidemiol</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>737</fpage>
          <lpage>43</lpage>
          <issue>8</issue>
          <volume>52</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ag&#252;erro-Torres</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Fratiglioni</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Viitanen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Winblad</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <mixed-citation>20. Griffiths RA, Good WR, Watson NP, O'Donnell HF, Fell PJ, Shakespeare JM. Depression, dementia and disability in the elderly. Br J Psychiatry. 1987;150:482-93.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Depression, dementia and disability in the elderly</article-title>
          <source>Br J Psychiatry</source>
          <date>
            <year>1987</year>
          </date>
          <fpage>482</fpage>
          <lpage>93</lpage>
          <volume>150</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Griffiths</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Good</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Watson</surname>
              <given-names>NP</given-names>
            </name>
            <name>
              <surname>O'Donnell</surname>
              <given-names>HF</given-names>
            </name>
            <name>
              <surname>Fell</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Shakespeare</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <mixed-citation>21. Wolf PA, Mitchell JB, Baker CS, Kannel WB, D'Agostino RB. Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med. 1998;158(3):229-34.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Impact of atrial fibrillation on mortality, stroke, and medical costs</article-title>
          <source>Arch Intern Med</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>229</fpage>
          <lpage>34</lpage>
          <issue>3</issue>
          <volume>158</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Wolf</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Mitchell</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Kannel</surname>
              <given-names>WB</given-names>
            </name>
            <name>
              <surname>D'Agostino</surname>
              <given-names>RB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <mixed-citation>22. Nielsen TR, Andersen BB, Kastrup M, Phung TK, Waldemar G. Quality of dementia diagnostic evaluation for ethnic minority patients: a Nationwide Study. Dement Geriatr Cogn Disord. 2011;31(5):388-96.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Quality of dementia diagnostic evaluation for ethnic minority patients: a Nationwide Study</article-title>
          <source>Dement Geriatr Cogn Disord</source>
          <date>
            <year>2011</year>
          </date>
          <fpage>388</fpage>
          <lpage>96</lpage>
          <issue>5</issue>
          <volume>31</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Nielsen</surname>
              <given-names>TR</given-names>
            </name>
            <name>
              <surname>Andersen</surname>
              <given-names>BB</given-names>
            </name>
            <name>
              <surname>Kastrup</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Phung</surname>
              <given-names>TK</given-names>
            </name>
            <name>
              <surname>Waldemar</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <mixed-citation>23. Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, et al. Conversion of mild cognitive impairment to dementia: predictive role of mild cognitive impairment subtypes and vascular risk factors. Dement Geriatr Cogn Disord. 2006;21(1):51-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Conversion of mild cognitive impairment to dementia: predictive role of mild cognitive impairment subtypes and vascular risk factors</article-title>
          <source>Dement Geriatr Cogn Disord</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>51</fpage>
          <lpage>8</lpage>
          <issue>1</issue>
          <volume>21</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ravaglia</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Forti</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Maioli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Martelli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Servadei</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Brunetti</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <mixed-citation>24. Pappas G, Queen S, Hadden W, Fisher G. The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986. N Engl J Med. 1993;329(2):103-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>1993</year>
          </date>
          <fpage>103</fpage>
          <lpage>9</lpage>
          <issue>2</issue>
          <volume>329</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Pappas</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Queen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hadden</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Fisher</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <mixed-citation>25. Rose G, Marmot MG. Social class and coronary heart disease. Br Heart J. 1981;45(1):13-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Social class and coronary heart disease</article-title>
          <source>Br Heart J</source>
          <date>
            <year>1981</year>
          </date>
          <fpage>13</fpage>
          <lpage>9</lpage>
          <issue>1</issue>
          <volume>45</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rose</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Marmot</surname>
              <given-names>MG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B26">
        <label>26</label>
        <mixed-citation>26. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects [the Cardiovascular Health Study]. Am J Cardiol. 1994;74(3):236-41.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prevalence of atrial fibrillation in elderly subjects [the Cardiovascular Health Study]: Am</article-title>
          <source>J Cardiol</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>236</fpage>
          <lpage>41</lpage>
          <issue>3</issue>
          <volume>74</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Furberg</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Psaty</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Manolio</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Gardin</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>VE</given-names>
            </name>
            <name>
              <surname>Rautaharju</surname>
              <given-names>PM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B27">
        <label>27</label>
        <mixed-citation>27. Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G, Stricker BH, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006;27(8):949-53.</mixed-citation>
        <element-citation publication-type="other">
          <person-group person-group-type="author">
            <name>
              <surname>Heeringa</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>van der Kuip</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Hofman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kors</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>van Herpen</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Stricker</surname>
              <given-names>BH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Atrial fibrillation and dementia: results from the Sao Paulo ageing &amp; health study</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: Atrial fibrillation (AF) is a controversial risk factor for dementia. OBJECTIVE: The objective of this study was to assess the association between AF and dementia in the "Sao Paulo Ageing &amp; Health" (SPAH) study participants. METHODS: SPAH is a cross-sectional, population-based study of elderly people living in a deprived neighborhood in Sao Paulo, Brazil. Dementia diagnosis was performed according to the 10/66 study group protocol based on Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria. Diagnosis of AF was made using a 12-lead electrocardiogram (ECG) recording, which was assessed by two cardiologists. Data on demographics and cardiovascular risk factors were also obtained. RESULTS: Dementia was diagnosed in 66 (4.3%) and AF in 36 (2.4%) of 1,524 participants with a valid ECG. The crude odds ratio (OR) for dementia in participants with AF was 2.8 (95% confidence interval [CI]: 1.0-8.1; p=0.06) compared with individuals without AF. When analyzing data according to sex, a positive relationship was found in women (OR 4.2; 95% CI: 1.24-15.1; p=0.03). After age-adjustment, however, this association was no longer significant (OR 2.2; 95% CI: 0.6-8.9; p=0.26). CONCLUSION: There was no independent association between AF and dementia in this sample. The prevalence of AF may be low in this population owing to premature cardiovascular death.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Atrial fibrillation</kwd>
        <kwd>cardiovascular disease</kwd>
        <kwd>dementia</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <fn id="tx-body2">
          <label>
            <bold>Atrial fibrillation and dementia: results from the Sao Paulo ageing &amp; health study</bold>
          </label>
          <p>
            <bold>Liz Andrea Kawabata-Yoshihara<sup>I</sup>; M&#225;rcia Scazufca<sup>II, III</sup>; Itamar de Souza Santos<sup>II</sup>; Aristarcho Whitaker<sup>I</sup>; Vitor S&#233;rgio Kawabata<sup>I</sup>; Isabela Martins Bense&#241;or<sup>I, II</sup>; Paulo Rossi Menezes<sup>II</sup>; Paulo Andrade Lotufo<sup>I, II</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Hospital Universit&#225;rio da Universidade de S&#227;o Paulo, S&#227;o Paulo, SP &#150; Brasil</p>
      <p><sup>II</sup>Faculdade de Medicina da Universidade de S&#227;o Paulo, S&#227;o Paulo, SP &#150; Brasil</p>
      <p><sup>III</sup>Hospital das Cl&#237;nicas da Faculdade de Medicina da Universidade de S&#227;o Paulo, S&#227;o Paulo, SP &#150; Brasil</p>
      <p>Mailing Address</p>
      <p>
        <bold>ABSTRACT</bold>
      </p>
      <p><bold>BACKGROUND: </bold> Atrial fibrillation (AF) is a controversial risk factor for dementia. </p>
      <p><bold> OBJECTIVE: </bold>The objective of this study was to assess the association between AF and dementia in the "Sao Paulo Ageing &amp; Health" (SPAH) study participants.</p>
      <p><bold> METHODS: </bold> SPAH is a cross-sectional, population-based study of elderly people living in a deprived neighborhood in Sao Paulo, Brazil. Dementia diagnosis was performed according to the 10/66 study group protocol based on Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria. Diagnosis of AF was made using a 12-lead electrocardiogram (ECG) recording, which was assessed by two cardiologists. Data on demographics and cardiovascular risk factors were also obtained. </p>
      <p><bold> RESULTS: </bold> Dementia was diagnosed in 66 (4.3%) and AF in 36 (2.4%) of 1,524 participants with a valid ECG. The crude odds ratio (OR) for dementia in participants with AF was 2.8 (95% confidence interval [CI]: 1.0&#150;8.1; p=0.06) compared with individuals without AF. When analyzing data according to sex, a positive relationship was found in women (OR 4.2; 95% CI: 1.24&#150;15.1; p=0.03). After age-adjustment, however, this association was no longer significant (OR 2.2; 95% CI: 0.6&#150;8.9; p=0.26). </p>
      <p><bold> CONCLUSION: </bold> There was no independent association between AF and dementia in this sample. The prevalence of AF may be low in this population owing to premature cardiovascular death.</p>
      <p><bold>Keywords: </bold> Atrial fibrillation; cardiovascular disease; dementia.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>It is estimated that most people with dementia already live in low- and middle-income nations<sup>1</sup>. However, there is very little data about risk factors for dementia in these populations<sup>2</sup>.</p>
      <p>The role of atrial fibrillation (AF) as a risk factor for dementia is still the subject of intense debate and conflicting results. Because dementia may be of vascular origin (even in the absence of documented stroke), some studies evaluated a possible role of AF in the development of dementia. The Rotterdam Study<sup>3</sup> showed an association between AF and risk of dementia and/or impaired cognitive function with a relative risk (RR) of 2.3 and a 95% confidence interval (95% CI) of 1.4&#150;3.7. Tilvis et al. found a positive association between AF and cognitive decline in a population-based sample of 650 individuals aged 75 years and older after 5 years (but not after 10 years) of follow-up<sup>4</sup>. Forti et al.<sup>5</sup>, studying individuals with mild cognitive impairment (MCI), found a 10.5/100 person-years conversion rate to dementia in this setting. The presence of AF was associated with a 4.6-fold higher risk in this group compared with individuals without AF (95% CI: 1.7&#150;12.5).</p>
      <p>On the other hand, Park et al. found no difference in cognitive function in individuals aged 60 years or older in the Cognition and Atrial Fibrillation Evaluation (CAFE) study at baseline<sup>6</sup> or after a three-year follow-up<sup>7</sup>. The Vantaa 85+Study<sup>8</sup> included residents aged 85 years or older (N=553) and found no difference in the frequency of dementia in subjects with and without AF at baseline (41.0% <italic>vs</italic>. 38.1%) and no difference in dementia incidence in individuals with AF after a mean follow-up of 3.5 years.</p>
      <p>There is conflicting data about this subject in medical literature. In addition to recent reports on AF prevalence in the elderly<sup>9</sup>, there is no information on the association between AF and dementia in the Brazilian population. The objective of this study was to assess a possible association between AF and dementia in a population of elderly people living in a deprived neighborhood in a metropolitan area of the city of S&#227;o Paulo.</p>
      <p>
        <bold>Methods</bold>
      </p>
      <p>The "S&#227;o Paulo Ageing &amp; Health" (SPAH) Study included a cross-sectional, one-phase, population-based study carried out in all residents aged 65 years or older living in an economically-deprived area of S&#227;o Paulo, Brazil. The main objective of the SPAH Study was to evaluate the prevalence of dementia as part of a collaborative program developed by the 10/66 Dementia Research Group. The study protocol is detailed elsewhere<sup>10,11</sup>. A substudy addressing ECG patterns was published previously<sup>9</sup>.</p>
      <p>
        <bold>Population and sample</bold>
      </p>
      <p>SPAH focused on all residents aged 65 years and older in 66 census sectors (smallest administrative areas) in the district of Butanta. The selected sectors were the most deprived ones in the district, including slums. Identification and recruitment was made by systematic knocking on doors of all households. Eligibility was based exclusively on age at time of recruitment. With the exception of institutionalized individuals, who were not included, all were invited to join the study. Whenever a census sector was selected, all residents were invited to participate in the study.</p>
      <p>Of 2,266 eligible participants aged 65 years and older, 2,072 (91.4%) consented to participate and were assessed for dementia by trained mental health professionals. The investigation for ECG changes started when the baseline assessment of SPAH was already underway. To minimize the influence of time elapsed from baseline data collection and ECG recording, individuals in whom an ECG recording was not obtained up to one year after SPAH inclusion were excluded from the analysis. Reasons for exclusion are shown in <xref ref-type="fig" rid="en_0312fig01-body2">Figure 1</xref>. Cases excluded from the analysis did not significantly differ from those with a valid ECG according to age, sex, or ethnicity.</p>
      <p content-type="asset">
        <fig id="en_0312fig01-body2">
          <graphic xlink:href="1678-4170-abc-99-06-1108-00106-gf01-en.jpg"/></fig>
      </p>
      <p>
        <bold>SPAH protocol</bold>
      </p>
      <p>Subjects who agreed to participate were invited to participate in a 90-minute interview carried out at the participant's home, approximately one week after recruitment by eight trained mental health workers. A caregiver was also identified for each participant <sup>10</sup>. Information about age, ethnicity, education, socioeconomic status, medical history, and cognitive and daily-life function was collected using a standardized questionnaire. A nurse assistant performed anthropometric assessments and blood pressure measurements at the participants' homes two to 15 days after the assessment interview. A venous blood sample was obtained after an overnight fast for fasting blood glucose and total and HDL-cholesterol measurement.</p>
      <p>
        <bold>Diagnosis of dementia</bold>
      </p>
      <p>Dementia diagnosis was based on DSM-IV criteria<sup>12</sup>. The presence of dementia was assessed using a dementia diagnostic tool developed by the 10/66 Dementia Research Group and validated for use in population-based studies of low and middle-income countries<sup>13</sup>. Information regarding cognitive impairment, with a detailed assessment of the onset and course of the dementia syndrome, was collected from both the participants and their caregivers. Diagnostic tools included the <italic>Community Screening Instrument for Dementia</italic> (CSI-D)<sup>14</sup>, a modified version of the CERAD ten-word list learning task with delayed recall; the animal naming verbal fluency task from the <italic>Consortium to Establish a Registry for Alzheimer's Disease</italic> (CERAD)<sup>15</sup>, a community-directed version of the <italic>Geriatric Mental State,</italic> (GMS) a semi-structured clinical interview for the assessment of mental status<sup>16,17</sup> and a structured neurological assessment to ascertain the presence of lateralizing signs, Parkinsonism, ataxia, apraxia, and primitive reflexes. The interview with caregivers consisted of inquiries about the participant's functional and cognitive performance according to the CSI-D and a brief history of the participant's functioning and cognitive decline based on the <italic>History and Aetiology Schedule Dementia Diagnosis and Subtype</italic> (HAS-DDS)<sup>18</sup>, which was applied when CSI-D pointed towards dysfunction. The HAS-DDS was also used to define probable dementia subtypes such as Alzheimer's disease, vascular dementia, or mixed dementia. The latter was defined as the presence of characteristics from either previous subtypes or a previous history of Parkinsonism.</p>
      <p>
        <bold>Diagnosis of atrial fibrillation</bold>
      </p>
      <p>The 12-lead resting electrocardiogram recordings were obtained at home. Recordings were independently analyzed by two cardiologists (A.W. and V.S.K.) using the Minnesota code. Agreement on the ECG diagnosis occurred in 92.9% of cases. When a disagreement occurred, a new analysis was done by both cardiologists. A consensus was reached in all cases.</p>
      <p>
        <bold>Other variables</bold>
      </p>
      <p>Age, education and monthly income were categorized for analysis. High blood pressure was defined as a positive medical history of high blood pressure, current treatment for high blood pressure, or systolic blood pressure <underline>&gt;</underline>140 mmHg and/or diastolic blood pressure <underline>&gt;</underline>90 mmHg. Diabetes mellitus was defined as a positive medical history of diabetes, current use of insulin or hypoglycemic oral drug treatment, or a fasting blood glucose level <underline>&gt;</underline>126 mg/dl.</p>
      <p>
        <bold>Ethical considerations</bold>
      </p>
      <p>The study was approved by the Institutional Review Board, and all participants provided signed informed consent. If they were unable to provide consent because of mental or physical incapacities, a signed agreement from the caregiver was obtained. When subjects were illiterate, the information sheet and consent form were read aloud and verbally-witnessed consent was acquired.</p>
      <p>
        <bold>Statistical analysis</bold>
      </p>
      <p>Data entry was carried out twice using the program EPIDATA 3.0, and a validity check was carried out to identify and correct data entry errors. Data was analyzed using SPSS 16.0. Pearson's Chi-square test and Fisher's exact test were used to compare categorical variables when appropriate. We also performed binary logistic regressions to evaluate the relationship between the presence of AF in ECG recordings and the diagnosis of dementia (all types), Alzheimer's disease, and vascular dementia. We used three models of inclusion for these analyses. In Model 1, all participants with a valid ECG recording were included. In Model 2, we excluded those individuals without AF in the ECG recording, but were using amiodarone and/or warfarin, as this could be evidence of paroxysmal AF. In Model 3, we considered the subgroup of participants receiving amiodarone and/or warfarin as individuals with AF. Data were analyzed as crude ratios and after age-adjustment. Point estimates as well as 95% CIs are shown. <italic>P</italic>-values less than 0.05 were considered statistically significant.</p>
      <p>
        <bold>Results</bold>
      </p>
      <p>Electrocardiogram recordings were obtained from 1,524 (73.6%) individuals. <xref ref-type="table" rid="en_0312tab01-body2">Table 1</xref> shows the baseline characteristics of the SPAH participants. Individuals with a valid ECG were then stratified by the presence of AF in the recording. AF was found in 37 (2,4%) subjects; 19/603 (3,2%) men and 18/921 (2,0%) women. Individuals with AF were older than those without AF (mean age, 77.7 &#177; 7.9 years vs. 72.1 &#177; 6.2 years; <italic>p</italic>&lt;0.01). Of the individuals with AF, 19 (51.4%) received antiplatelet or anticoagulant therapy, 10 (27.0%) received aspirin, 8 (21.6%) received warfarin, and 1 (2.7%) received ticlopidine. Fifteen (40.5%) individuals received rate- and/or rhythm-control medication; 8 (21.6%) received digoxin, 3 (8.1%) received beta-blockers, 2 (5.4%) received amiodarone, 1 (2.7%) received calcium-channel blockers, and 1 (2.7%) received beta-blockers and calcium-channel blockers.</p>
      <p content-type="asset">
        <table-wrap id="en_0312tab01-body2">
          <graphic xlink:href="1678-4170-abc-99-06-1108-00106-gt01-en.jpg"/></table-wrap>
      </p>
      <p>Of the sample with an ECG recording, 66 (4.3%) had a dementia diagnosis, including 44 of 921 women (4.8%) and 22 of 603 men (3.6%). In this ancillary study, 25 (37.9%) individuals had Alzheimer's disease, 25 (37,9%) had vascular dementia, and 16 (24.2%) had mixed dementia. <xref ref-type="table" rid="en_0312tab02-body2">Table 2</xref> shows the odds ratio (crude and age-adjusted) for dementia (all subtypes), Alzheimer's disease, and vascular dementia comparing individuals with and without AF (Model 1). Data are also stratified by sex. Excluding the participants who did not present with AF in the ECG recording, but were receiving amiodarone and/or warfarin (Model 2) at the time of evaluation did not materially alter the results. When we considered participants on amiodarone and/or warfarin treatment as individuals with AF (Model 3), no association reached statistical significance.</p>
      <p content-type="asset">
        <table-wrap id="en_0312tab02-body2">
          <graphic xlink:href="1678-4170-abc-99-06-1108-00106-gt02-en.jpg"/></table-wrap>
      </p>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>AF and dementia are chronic disorders associated with high morbidity, mortality, and disability<sup>19,20,21</sup>. In our study, we found an association between AF and dementia in women, but the association vanished after adjustment for age, suggesting that there is no independent correlation between these two conditions. No association was found for men or when analyzing dementia subtypes.</p>
      <p>It is difficult to establish direct comparisons among studies that address the relationship between AF and dementia because of methodological differences. One of the main barriers is the fact that instruments used to diagnose dementia and/or cognitive impairment vary widely. In low-income populations, education and cultural differences may also influence the results<sup>22</sup>. In this population-based study, we used a validated algorithm specifically developed for dementia diagnosis in low- and middle-income populations based on DSM-IV criteria that consists of multiple diagnostic tools and is corroborated by earlier studies<sup>13</sup>.</p>
      <p>As this is a subject of debate in the medical literature and data from previous studies led to conflicting conclusions, it is important to point out reasons that may be responsible for our negative results and the positive results of other authors. First, this is a population-based study. Some authors have found a positive result in samples of individuals with mild cognitive impairment<sup>5,23</sup>. In this type of setting, a higher conversion to dementia is expected, favoring positive results. Moreover, supposing a true association between AF and dementia exists only in a subgroup of individuals, this approach may "select" individuals in whom this process has already started, which also favors a positive result, leading to mistaken conclusions for the whole population.</p>
      <p>Our results contrast with the findings of the Rotterdam Study<sup>3</sup>, which included younger individuals (inclusion started at age 55 years). Moreover, their results pointed to a stronger association between AF and dementia in younger individuals (aged &lt;75 years). This is a possible explanation for differences observed in their study when compared with ours. As age advances, other mechanisms of disease may become prominent and an association with AF will be weakened. In a low-income sample such as the one in the present study, a survival bias due to premature all-cause<sup>24</sup> and cardiovascular<sup>25</sup> deaths is also expected. This may be at least partially responsible for the smaller rates of AF observed in our study (AF prevalence 2.0% in women and 3.2% in men), compared to the Cardiovascular Health Study (4.8% in women and 6.2% in men)<sup>26</sup> and Rotterdam Study (7.5% in women and 9.7% in men)<sup>27</sup>. This lower prevalence may make it difficult to observe an association between dementia and AF.</p>
      <p>Our study has some limitations. The small number of individuals with concomitant AF and dementia impaired the analysis by dementia subtypes. A cross-sectional design is not sufficient to establish a causal relationship between two conditions. However, a lack of association in this kind of study could indicate that a causal relationship may not exist. A single electrocardiogram, utilized for the diagnosis of AF, does not allow the diagnosis of paroxysmal AF and does not identify individuals successfully treated with rhythm control treatment strategies. However, excluding those patients with normal sinus rhythm who were receiving treatment potentially directed to paroxysmal AF (Model 2), as well as considering them as AF patients (Model 3) did not significantly alter the results.</p>
      <p>
        <bold>Conclusion</bold>
      </p>
      <p> Our study did not find an independent association between AF and dementia in a population-based sample living in a low-income area in Brazil. The prevalence of AF may be low in this population owing to premature death, especially by cardiovascular disease.</p>
      <p>
        <bold>Acknowledgements</bold>
      </p>
      <p>This study was supported by the Wellcome Trust and FAPESP (Funda&#231;&#227;o de Apoio &#224; Pesquisa do Estado de S&#227;o Paulo).</p>
      <p>
        <bold> Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>This study was funded by FAPESP and Wellcome Trust.</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This article is part of the thesis of doctoral submitted by Liz Andrea Kawabata-Yoshihara, from Faculdade de Medicina da USP.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
</article>
